<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0058">
 <label>58</label>
 <mixed-citation publication-type="web">
  <person-group person-group-type="author">
   <collab>Evaluation of the efficacy and safety of camostat mesilateÂ </collab>
  </person-group>+
  <person-group person-group-type="editor">
   <collab>hydroxychloroquine combination</collab>
  </person-group> therapy in hospitalized patients 
  <person-group person-group-type="editor">
   <collab>with moderate</collab>
  </person-group> COVID-19 infection. Heinrich-Heine University, Duesseldorf, Germany. 
  <year>2020</year>. Available from: 
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04338906" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04338906</ext-link>.
 </mixed-citation>
</ref>
